VLNS.TO
Valens Company Inc.
Price:  
1.01 
CAD
Volume:  
59,486.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VLNS.TO WACC - Weighted Average Cost of Capital

The WACC of Valens Company Inc. (VLNS.TO) is 8.4%.

The Cost of Equity of Valens Company Inc. (VLNS.TO) is 9.05%.
The Cost of Debt of Valens Company Inc. (VLNS.TO) is 5.00%.

Range Selected
Cost of equity 7.00% - 11.10% 9.05%
Tax rate 5.10% - 9.70% 7.40%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.7% - 10.0% 8.4%
WACC

VLNS.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.76 1.14
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 11.10%
Tax rate 5.10% 9.70%
Debt/Equity ratio 0.19 0.19
Cost of debt 5.00% 5.00%
After-tax WACC 6.7% 10.0%
Selected WACC 8.4%

VLNS.TO's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for VLNS.TO:

cost_of_equity (9.05%) = risk_free_rate (3.45%) + equity_risk_premium (5.60%) * adjusted_beta (0.76) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.